Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein shisa-6 (SHISA6) is a single-pass transmembrane auxiliary protein of the Shisa family, highly enriched in neuronal tissue—especially in the hippocampus and cerebellum—where it binds to and regulates AMPA-type glutamate receptors (AMPARs)[1][4][5]. SHISA6 modulates AMPAR trafficking, promotes their retention in the postsynaptic density by interacting with PDZ-containing scaffolding proteins such as PSD-95, and alters AMPAR channel kinetics by slowing desensitization and favoring sustained currents, thereby stabilizing synaptic transmission and supporting synaptic plasticity[1][2][3][4]. It is crucial for neuronal circuit refinement, memory formation, and may have neuroprotective properties. Mutational or knockout studies in mice show significant impacts on synaptic function and cognitive processes but SHISA6 is not yet a direct pharmacological target or disease biomarker[1][2][3][5]. It may also suppress canonical Wnt signaling in developmental contexts[2][6].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein shisa-6 (SHISA6).